Vaxtex Cotfab Limited (NSE:VCL)
India · Delayed Price · Currency is INR 1.540
+0.060 (4.05%)
Oct 19, 2026, 3:29 PM IST
Vaxtex Cotfab Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 111.66 | 111.66 | 52.53 | 166.2 | 756.22 | 619.07 |
Other Revenue | - | - | - | 0.34 | 5.31 | - |
| 111.66 | 111.66 | 52.53 | 166.54 | 761.53 | 619.07 | |
Revenue Growth | 112.56% | 112.56% | -68.46% | -78.13% | 23.01% | 136.70% |
Cost of Revenue | 87.01 | 87.01 | 50.56 | 218.64 | 706.91 | 540.51 |
Gross Profit | 24.66 | 24.66 | 1.98 | -52.1 | 54.62 | 78.56 |
Selling, General & Admin | 1.72 | 1.98 | 0.93 | 2.56 | 13.04 | 14.9 |
Other Operating Expenses | 2.64 | 3.61 | 5.87 | 9.89 | 37.71 | 33.55 |
Operating Expenses | 4.45 | 5.81 | 7.84 | 13.98 | 53.53 | 51.44 |
Operating Income | 20.21 | 18.85 | -5.87 | -66.08 | 1.09 | 27.12 |
Interest Expense | -0.63 | -0.73 | -1.13 | -0.66 | -6.31 | -10.79 |
Interest & Investment Income | - | 5.65 | 16.07 | 4.92 | 3.61 | 3.76 |
Other Non Operating Income (Expenses) | 28.18 | - | - | -0 | -0 | -0 |
EBT Excluding Unusual Items | 47.77 | 23.76 | 9.08 | -61.82 | -1.62 | 20.09 |
Gain (Loss) on Sale of Investments | - | -8.11 | -5.05 | - | -2.34 | - |
Gain (Loss) on Sale of Assets | - | 10.95 | - | -26.53 | - | - |
Other Unusual Items | - | 24.02 | 0.09 | - | 15.54 | - |
Pretax Income | 47.77 | 50.62 | 4.12 | -88.34 | 11.59 | 20.09 |
Income Tax Expense | -4.81 | -4.64 | -4.72 | - | 0.27 | 5.23 |
Net Income | 52.58 | 55.26 | 8.84 | -88.34 | 11.32 | 14.86 |
Net Income to Common | 52.58 | 55.26 | 8.84 | -88.34 | 11.32 | 14.86 |
Net Income Growth | 414.67% | 525.34% | - | - | -23.82% | 733.32% |
Shares Outstanding (Basic) | 182 | 184 | 184 | 151 | 103 | 100 |
Shares Outstanding (Diluted) | 182 | 184 | 184 | 151 | 103 | 100 |
Shares Change | 1.21% | - | 22.07% | 46.02% | 2.69% | - |
EPS (Basic) | 0.29 | 0.30 | 0.05 | -0.59 | 0.11 | 0.15 |
EPS (Diluted) | 0.29 | 0.30 | 0.05 | -0.59 | 0.11 | 0.15 |
EPS Growth | 409.31% | 526.46% | - | - | -25.81% | 733.34% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -21.86 | 12.3 | -131.36 | -109.22 | 63.81 |
Free Cash Flow Per Share | - | -0.12 | 0.07 | -0.87 | -1.06 | 0.64 |
Gross Margin | 22.08% | 22.08% | 3.76% | -31.28% | 7.17% | 12.69% |
Operating Margin | 18.10% | 16.88% | -11.17% | -39.67% | 0.14% | 4.38% |
Profit Margin | 47.09% | 49.48% | 16.82% | -53.04% | 1.49% | 2.40% |
Free Cash Flow Margin | - | -19.57% | 23.41% | -78.87% | -14.34% | 10.31% |
EBITDA | 20.23 | 19.07 | -4.83 | -64.55 | 3.87 | 30.12 |
EBITDA Margin | 18.12% | 17.08% | -9.19% | -38.76% | 0.51% | 4.87% |
D&A For EBITDA | 0.02 | 0.23 | 1.04 | 1.53 | 2.79 | 2.99 |
EBIT | 20.21 | 18.85 | -5.87 | -66.08 | 1.09 | 27.12 |
EBIT Margin | 18.10% | 16.88% | -11.17% | -39.67% | 0.14% | 4.38% |
Effective Tax Rate | - | - | - | - | 2.32% | 26.03% |
Revenue as Reported | 139.84 | 144.25 | 63.82 | 171.46 | 765.13 | 622.83 |
Advertising Expenses | - | 0.09 | 0.07 | 0.45 | 0.06 | 0.02 |